Mistletoe therapy is emerging as a powerful integrative approach in cancer care, offering relief from the side effects of conventional treatments and enhancing immune response. In India, awareness about this plant-based therapy is steadily growing, thanks to institutions like ABNOBA India, which brings German pharmaceutical expertise through its collaboration with ABNOBA GmbH, based in Pforzheim, Germany.
The cost of mistletoe cancer therapy in India depends on multiple factors: the patient's condition, the type and strength of mistletoe extract used, frequency of administration, and whether it's done at home or in a clinical setting. Typically, patients can expect to spend anywhere from ₹10,000 to ₹30,000 per month for a supervised course of therapy. This includes the cost of the vials (imported from Germany), medical consultations, and application support.
While this may seem high for some, many patients report improved quality of life, better tolerance to chemotherapy, and reduced fatigue and nausea after using mistletoe therapy. Since it is considered a complementary (not primary) treatment, health insurance in India may not cover it, though select wellness centers offer package plans.
ABNOBA India ensures that every product meets strict European standards and is distributed through authorized medical networks across India. For those exploring holistic, integrative options alongside cancer treatment, mistletoe therapy presents a promising path. Always consult your oncologist or a trained integrative medicine expert before starting mistletoe-based protocols.
